Inside informationEnglish
Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel
The file is served by the AMF. We do not host a copy.
Document type
- Filed
- 07/07/2026, 23:04
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 082542_20260707
Filed the same day
- OPRA privilégiée pour la mise en oeuvre du retour aux actionnaires suite à la cession de NovacelInside informationFrench